Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ (19,667)	$ (9,951)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	4,806	4,984
Amortization of acquisition related intangible assets	5,837	5,837
Non-cash operating lease cost	1,633	1,322
Loss on disposal of property and equipment	1,852	0
Stock-based compensation expense	11,428	10,502
Deferred income taxes	(4,484)	(3,491)
Provision for credit losses	74	379
Provision for inventory	2,607	3,701
Changes in operating assets and liabilities:
Accounts receivable, net	(201)	(4,983)
Inventories	(8,257)	(3,933)
Prepaid expenses, other current and long-term assets	818	(456)
Accounts payable	(1,319)	533
Operating lease liabilities	(1,575)	(1,054)
Accrued expenses, other current and long-term liabilities	914	115
Income taxes	108	423
Net cash (used in) provided by operating activities	(5,426)	3,928
Cash flows from investing activities:
Purchases of property and equipment	(3,587)	(4,957)
Net cash used in investing activities	(3,587)	(4,957)
Cash flows from financing activities:
Proceeds from employee stock purchase program	456	0
Cash paid for tax withheld on vested restricted stock awards	(2,159)	(935)
Proceeds from exercises of equity awards	37	15
Payments made on finance leases	0	(284)
Contingent consideration payout	0	(4,315)
Repurchases of common stock	(5,000)	0
Net cash used in financing activities	(6,666)	(5,519)
Exchange rate impact on cash	3	(61)
Decrease in cash and cash equivalents	(15,676)	(6,609)
Cash and cash equivalents at beginning of period	86,327	94,386
Cash and cash equivalents at end of period	70,651	87,777
Non-cash investing activities:
Right-of-use assets obtained in exchange for operating lease liabilities	0	11,589
Purchases of property and equipment included in accounts payable and accrued expenses	$ 749	$ 108